58
Participants
Start Date
February 28, 2015
Primary Completion Date
September 30, 2017
Study Completion Date
October 31, 2019
Dopamine hydrochloride
Active drug substance 1.5 mg in 1 mL IV Infusion Minimum dose = 5mcg/kg/min Maximum dose = 20mcg/kg/min
Dextrose 5%
IV Infusion Minimum dose = 5mcg/kg/min Maximum dose = 20mcg/kg/min
Coombe Women and Infants University Hospital, Dublin
Katholieke Universiteit Leuven, Oude God
Univerzita Karlova v Praze, Prague
University Hospital Antwerp, Antwerp
University of Alberta, Edmonton
Centre hospitalier universitaire Sainte-Justine, Montreal
Cork University Maternity Hospital, Cork
Royal College of Surgeons in Ireland, Dublin
University College Dublin, Dublin
Royal Maternity Hospital, Belfast
Collaborators (1)
Cork University Hospital
OTHER
Coombe Women and Infants University Hospital
OTHER
Royal College of Surgeons, Ireland
OTHER
National Maternity Hospital, Ireland
OTHER
University Hospital, Antwerp
OTHER
KU Leuven
OTHER
University of Alberta
OTHER
St. Justine's Hospital
OTHER
Institute for the Care of Mother and Child, Prague, Czech Republic
OTHER
GABO:mi
INDUSTRY
BrePco Biopharma Limited
OTHER
University College, London
OTHER
Institut National de la Santé Et de la Recherche Médicale, France
OTHER_GOV
Clininfo S.A.
INDUSTRY
University College Cork
OTHER